• IJMPO
image
Welcome,
Change Password

"Redefining the management of Her2 negative early breast cancer in the era of precision medicine".

"Redefining the management of Her2 negative early breast cancer in the era of precision medicine".

Dr. Tejinder Singh

Watch Video

Complexities to consensus : Highlights from ABC6 Guidelines

Complexities to consensus : Highlights from ABC6 Guidelines

Dr. Fatima Cardoso

Watch Video

Triple positive breast cancer an enigma

Triple positive breast cancer an enigma

Dr. B K Smruti

Watch Video

Immunotherapy in advance NSCLC :Is Newer data of value or repetition?

Immunotherapy in advance NSCLC :Is Newer data of value or repetition?

Dr. Solange Peters 

Watch Video

Second line therapy after Immunotherapy – Are there any specific choices?

Second line therapy after Immunotherapy – Are there any specific choices?

Dr. TVS Tilak

Watch Video

Biomarker in Immunotherapy – Are all of them required?

Biomarker in Immunotherapy – Are all of them required?

Dr. Navneet Singh

Watch Video

Is Resistance to 3rd Gen TKI in 1st Line Fuelling New Therapeutic Strategies?

Is Resistance to 3rd Gen TKI in 1st Line Fuelling New Therapeutic Strategies?

Dr. Tony Mok

Watch Video

Evolving landscape of novel oncogenic drivers in NSCLC and therapies: Beyond the conventional

Evolving landscape of novel oncogenic drivers in NSCLC and therapies: Beyond the conventional

Dr. Natasha Leighl

Watch Video

EGFR and ALK mutation positive Lung cancer – How is the outcome for Indian patients?

EGFR and ALK mutation positive Lung cancer – How is the outcome for Indian patients?

Dr. Kumar Prabhash

Watch Video

The brain metastsis in NSCLC: are current therapies changing the treatment paradigms?

The brain metastsis in NSCLC: are current therapies changing the treatment paradigms?

Dr. Lizza Hendriks 

Watch Video

Endpoints in Adjuvant trials in Immunotherapy and targeted therapy – Is this the way to go?

Endpoints in Adjuvant trials in Immunotherapy and targeted therapy – Is this the way to go?

Dr.Prabhat Malik

Watch Video

Panel Discussion : Real world perspective on immunotherapy in NSCLC “implementing state of the art in the clinic"

Panel Discussion : Real world perspective on immunotherapy in NSCLC “implementing state of the art in the clinic"

Moderator : Dr. Ullas Batra 

Watch Video

Panel Discussion : Real world perspective on oncogene driven NSCLC “implementing precision oncology in the clinic

Panel Discussion : Real world perspective on oncogene driven NSCLC “implementing precision oncology in the clinic

Moderator : Vanita Noronha

Watch Video